Event Location:
Berkeley City Club
1315 Durant Avenue, Berkeley CA 94704
Schedule:
5:00 - 5:45 pm Registration Networking Reception
5:45 - 6:30 pm Buffet Dinner
6:30 - 8:00 pm Presentations
Erica Brust, Process Engineer, Juno Therapeutics
Mark Thomas, Associate Director, Plant and Facilities Engineering Boehringer-Ingelheim
Synopsis
ISPE San Francisco Bay Area Chapter will host a panel on May 17th, 2018 covering key elements of successful Technology Transfer with industry experts. We will focus on the prerequisites for technology transfer, specific risk-based approaches, and deliverables to enable success during transfer. Case studies detailing lessons learned will show the importance of a risk-based approach, cross-functional collaboration, and comparability during transfer. Come ready with questions for a discussion with the presenters.
Mark Thomas, Associate Director, Plant and Facilities Engineering, Boehringer-Ingelheim
Mark Thomas is a Principal Process Engineer with 15 years of process engineering experience managing capital engineering projects in all phases of the project life cycle. Past projects include implementing new upstream and downstream manufacturing equipment, and modifying existing equipment to make it reliable and optimized for multi-product production campaigns. In addition, Mark has lead engineering groups capable of managing complex engineering projects. These responsibilities cover process equipment and utility evaluations, process technical transfer, client and regulatory agency iteration, change control documentation, performing factory and site acceptance tests (FATs/SATs), installation, commissioning, debugging, optimization, supporting Validation and training personnel.
Erica Brust, Process Engineer, Juno Therapeutics
Erica Brust is a Process Engineer at Juno Therapeutics, a Celgene company, focused on technology transfer and process support for lentiviral vector and CAR-T cell therapy manufacturing processes. Her background is in biochemical engineering, with industry experience in vaccine process development, autologous and allogeneic process development and technology transfer.